Related Experiment Video
Updated: May 26, 2025

09:35
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
13.1K
A nucleosome switch primes hepatitis B virus infection
Nicholas A Prescott1, Tracy Biaco2, Andrés Mansisidor3
1Tri-Institutional PhD Program in Chemical Biology, New York, NY 10065, USA; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Cell
|February 21, 2025
Summary
Chronic hepatitis B virus (HBV) infection involves viral DNA (cccDNA) forming a minichromosome. Nucleosome occupancy on this cccDNA regulates viral X gene transcription, offering a potential therapeutic target for HBV.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Chronic hepatitis B virus (HBV) infection is a leading cause of liver disease and hepatocellular carcinoma.
- HBV establishes an episomal minichromosome (cccDNA) upon infection, requiring viral X gene expression to overcome host silencing.
- The interplay between cccDNA chromatin structure and X gene transcription remains unclear.
Purpose of the Study:
- To investigate the role of cccDNA chromatinization in regulating HBV X gene transcription.
- To explore potential therapeutic strategies targeting cccDNA structure for HBV treatment.
Main Methods:
- Development of a reconstituted HBV minichromosome platform.
- In situ validation of findings in primary human hepatocytes.
- Assessment of the impact of the chromatin-destabilizing molecule CBL137.
Main Results:
- Nucleosome occupancy on the HBV cccDNA minichromosome was found to regulate X gene transcription.
- The chromatin-destabilizing agent CBL137 effectively inhibited full-length X transcription.
- CBL137 demonstrated inhibition of HBV infection in primary human hepatocytes.
Conclusions:
- cccDNA chromatin structure is a critical regulator of HBV X gene expression.
- Targeting cccDNA chromatin offers a promising therapeutic avenue for chronic HBV infection.
- Inhibition of X gene transcription via chromatin modulation presents a novel strategy against HBV.

